Global Viscosupplementation Market Size & Outlook
Global viscosupplementation market, 2018-2030 (US$M)
Related Markets
Global viscosupplementation market highlights
- The global viscosupplementation market generated a revenue of USD 4,818.6 million in 2023 and is expected to reach USD 9,143.7 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 9.6% by 2030.
- In terms of segment, single injection accounted for a revenue of USD 2,073.9 million in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,818.6 million |
| Market revenue in 2030 | USD 9,143.7 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
Other key industry trends
- In terms of revenue, the North America accounted for 37.5% of the global viscosupplementation market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Canada is the fastest growing regional market and is projected to reach USD 153.0 million by 2030.
Single injection was the largest segment with a revenue share of 43.04% in 2023. Horizon Databook has segmented the Global viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
The product pipelines recent research and development advancements are anticipated to propel the market growth over the forecast period. An example is the completion of clinical trials by Bone Therapeutics S.A. in April 2018 for their intra-articular injection, JTA-004, specifically designed for knee osteoarthritis.
Furthermore, the market is witnessing new products that offer more effective results. Anika Therapeutics, Inc., for instance, showcased their innovative hyaluronic acid-based scaffold called Hyalofast for cartilage repair at the International Cartilage Regeneration and Joint Preservation Society (ICRS) in June 2019. These advancements in R&D and the introduction of novel products contribute to expanding the viscosupplementation market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global viscosupplementation market size, by region, 2018-2030 (US$M)
Top 10 countries: Viscosupplementation market size, 2023 (US$M)
Global viscosupplementation market share, by product, 2023 & 2030 (%, US$M)
Viscosupplementation market: Opportunity assessment by country
Global viscosupplementation market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
